Tel: +86 (0)571 8102-5280
Email: sales@molcore.com
Language :
English
中文版
日本語
Search
Home
About Us
CRO&CDMO
Services
Custom Synthesis
Process development
IP & Quality
Facility
R&D Center
Manufacturing
Products
Contact Us
Name Index L
Home
Sitemap
Name Index L
Recently searched keywords
929895-49-8
,
1196707-11-5
,
17701-61-0
,
859518-20-0
,
56442-17-2
,
1029720-19-1
,
897030-99-8
,
860786-63-6
,
728038-73-1
,
5710-64-5
,
233759-98-3
,
2096331-76-7
,
1269802-68-7
,
6659-62-7
,
1144035-43-7
,
870717-92-3
,
926294-07-7
,
96682-19-8
,
3055-95-6
,
1799412-41-1
,
29548-92-3
,
80258-33-9
,
147150-35-4
,
144851-61-6
,
4996-21-8
,
198474-61-2
,
101-84-8
,
1643479-47-3
,
69964-40-5
,
204516-31-4
,
381717-91-5
,
667463-62-9
,
749806-66-4
,
1378802-25-5
,
88308-37-6
,
29106-49-8
,
1254348-96-3
,
209328-85-8
,
92259-19-3
,
3972-56-3
,
201217-86-9
,
124522-52-7
,
35354-86-0
,
1082949-67-4
,
259809-79-5
,
475058-41-4
,
76401-90-6
,
735275-80-6
,
1177334-96-1
,
2034-23-3
,
475301-86-1
,
80875-98-5
,
38628-51-2
,
84845-75-0
,
371974-08-2
,
61655-77-4
,
212631-79-3
,
1261827-91-1
,
28159-98-0
,
69-23-8
Products Sitemap
Cas Index
1
2
3
4
5
6
7
8
9
Name Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Name Index L
SKU
Chemical Name
Molecular Formula
MC807357
417714-14-8 | Lenvatinib Impurity g
MC807356
1533519-98-0 | Lesinurad Impurity 7
MC807355
1533519-93-5 | Lesinurad Impurity B
MC807352
1446263-38-2 | Linagliptin iMpurity E
MC807350
1646355-34-1 | Linagliptin impurity R
MC807335
30508-27-1 | Licoricidin
MC807324
956136-95-1 | Pradigastat
MC807226
894002-50-7 | LDN 212320
MC807205
862901-87-9 | LT175
MC807106
58471-53-7 | L-Aspartic acid, L-a-aspartyl-
C8H12N2O7
MC807095
554-13-2 | Lithium carbonate
CLi2O3
MC807023
213476-12-1 | Lansoprazole n-oxide
MC806884
117678-38-3 | Levofloxacin n-oxide
MC806849
1006062-28-7 | Losartan Impurity D
C41H37ClN6O
MC806658
880762-37-8 | L-Cysteine,N-[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]-S-(triphenylmethyl)-
MC806615
1642303-38-5 | Lenrispodun phosphate
C29H29FN7O5P
MC806080
1185240-53-2 | Lumefantrine-d18
MC805956
121250-47-3 | LinoleicAcid
C18H32O2
MC805807
1246820-62-1 | Losartan-d4 Carboxylic Acid
MC805781
1256364-24-5 | Lithium triisopropyl 2-(6-methylpyridyl)borate
C15H27BLiNO3
MC805681
1262036-49-6 | LY2886721 HCl
MC805348
1393822-91-7 | Lithium (5-cyano-2-pyridyl)-trihydroxy-boranuide
C6H6BLiN2O3
MC805347
1393-92-6 | Litmus
MC805217
1454682-72-4 | LY-3009120(DP-4978)
C23H29FN6O
MC804718
186204-32-0 | Lurasidone Metabolite 14283 HCl
MC804717
186204-33-1 | Lurasidone Inactive Metabolite 14326
MC804407
226578-51-4 | Levofloxacin mesylate
C19H24FN3O7S
MC804244
25721-92-0 | Lanthanum acetate sesquihydrate
C12H24La2O15
MC804112
2922-61-4 | Lithium 2-oxopropanoate
C3H3LiO3
MC802461
74639-14-8 | Liquiritin apioside
Prev
6
7
8
9
10
11
12
13
Next
© Copyright 2015-2024 Hangzhou MolCore BioPharmatech Co.,Ltd. All rights reserved.